Acceptability and willingness to pay for a hypothetical HIV vaccine in Brazil and the implications: a cross-sectional study-Reference-Cited by-同舟云学术

Acceptability and willingness to pay for a hypothetical HIV vaccine in Brazil and the implications: a cross-sectional study

Published:2024-07-26 Issue: Volume: Page:1-10
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Nogueira Vinícius Gonçalves¹,Reis Edna Afonso²^ORCID,Godman Brian³⁴^ORCID,Martin Antony Paul⁵⁶^ORCID,Godói Isabella Piassi Dias¹⁷^ORCID

Affiliation:

1. Institute of Pharmaceutical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

2. Department of Statistics, Exact Sciences Institute, Federal University of Minas Gerais, Belo Horizonte, Brazil

3. Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, UK

4. School of Pharmacy, Department of Public Health and Pharmacy Management, Sefako Health Sciences University, Pretoria, South Africa

5. Faculty of Health & Life Sciences, University of Liverpool, Liverpool, UK

6. QC Medica, York, North Yorkshire, UK

7. Health Technology Assessment Center - Management, Economics, Health Education and Pharmaceutical Services (GEESFAR/NATS/UFRJ) of the Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

Funder

not funded

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2024.2384543

Reference66 articles.

1. Epidemiologia e aspectos imunopatológicos do vírus da imunodeficiência humana (HIV): revisão de literatura

2. Manifestações clínicas e orofaciais de pacientes vivendo com HIV na era pós-HAART

3. Brasil. Ministério da Saúde. Aids/Hiv. 2023 [cited 2023 Nov 28]. Available from: https://www.gov.br/saude/pt-br/assuntos/saude-de-a-a-z/a/aids-hiv

4. Human Immunodeficiency Virus (HIV)

5. Administrator. HIV: sintomas transmissão e prevenção [HIV: symptoms transmission and prevention]. 2022 [cited 2023 Aug 9]. Available from: https://www.bio.fiocruz.br/index.php/br/sintomas-transmissao-e-prevencao-nat-hiv